neurogenic detrusor overactivity

Showing 1 - 19 of 19

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Neurogenic Bladder, Lower Urinary Tract Symptoms, Overactive Bladder Trial (Standard number of injection sites, Reduced number

Not yet recruiting
  • Neurogenic Bladder
  • +4 more
  • Standard number of injection sites
  • Reduced number of injection sites
  • (no location specified)
Sep 22, 2023

Neurogenic Detrusor Overactivity Trial in Worldwide (mirabegron)

Not yet recruiting
  • Neurogenic Detrusor Overactivity
  • Palo Alto, California
  • +11 more
Jan 16, 2023

Neurogenic Detrusor Overactivity Trial in Worldwide (Mirabegron)

Completed
  • Neurogenic Detrusor Overactivity
  • Randwick, New South Wales, Australia
  • +31 more
Sep 21, 2022

Spinal Cord Injuries, Neurogenic Bladder, Neurogenic Detrusor Overactivity Trial (Neuromodulation)

Not yet recruiting
  • Spinal Cord Injuries
  • +3 more
  • Neuromodulation
  • (no location specified)
Aug 12, 2022

Neurogenic Detrusor Overactivity Trial (Vibegron)

Not yet recruiting
  • Neurogenic Detrusor Overactivity
  • (no location specified)
Aug 4, 2022

Neurogenic Detrusor Overactivity Trial in Colombia, United States (Darifenacin)

Terminated
  • Neurogenic Detrusor Overactivity
  • San Diego, California
  • +11 more
May 13, 2022

Neurogenic Detrusor Overactivity, Overactive Bladder, Pharmacokinetics of Mirabegron Trial in Worldwide (Mirabegron)

Completed
  • Neurogenic Detrusor Overactivity
  • +2 more
  • Edegem, Belgium
  • +12 more
Jul 13, 2021

Overactive Bladder, Neurogenic Detrusor Overactivity Trial in Aalborg, Aarhus, Warsaw (mirabegron)

Completed
  • Overactive Bladder
  • Neurogenic Detrusor Overactivity
  • Aalborg, Denmark
  • +2 more
Jun 28, 2021

Neurogenic Detrusor Overactivity Trial in Brussels (4 mg Fesoterodine ER tablet from Zwickau, 4 mg fesoterodine ER tablet from

Completed
  • Neurogenic Detrusor Overactivity
  • 4 mg Fesoterodine ER tablet from Zwickau
  • +3 more
  • Brussels, Bruxelles-capitale, Région DE, Belgium
    Brussels Clinical Research Unit
May 6, 2021

Neurogenic Detrusor Overactivity Trial in Brussels (Fesoterodine BIC SR4 fasted (Treatment A in Part A, Treatment G in Part B),

Completed
  • Neurogenic Detrusor Overactivity
  • Fesoterodine BIC SR4 fasted (Treatment A in Part A, Treatment G in Part B)
  • +4 more
  • Brussels, Bruxelles-capitale, Région DE, Belgium
    Brussels Clinical Research Unit
Feb 8, 2021

Neurogenic Detrusor Overactivity Trial in Worldwide (Rec 0/0438 1 mg or Rec 0/0438 2 mg, )

Completed
  • Neurogenic Detrusor Overactivity
  • Rec 0/0438 1 mg or Rec 0/0438 2 mg
  • placebo
  • Praha, Czechia
  • +8 more
Jan 26, 2021

Neurogenic Detrusor Overactivity, Spinal Cord Injury Trial in Badalona, Nottwil, Zurich (external electric pudendal nerve

Withdrawn
  • Neurogenic Detrusor Overactivity
  • Spinal Cord Injury
  • external electric pudendal nerve stimulation
  • Badalona, Barcelona, Spain
  • +2 more
Jul 19, 2019

Neurogenic Detrusor Overactivity Trial in Worldwide (Solifenacin succinate)

Completed
  • Neurogenic Detrusor Overactivity
  • Solifenacin succinate
  • Tarrytown, New York
  • +20 more
Apr 10, 2019

Neurogenic Detrusor Overactivity, Pediatric Trial in Worldwide (Solifenacin succinate)

Completed
  • Neurogenic Detrusor Overactivity
  • Pediatric
  • Solifenacin succinate
  • Tarrytown, New York
  • +7 more
Oct 17, 2018

Overactive Bladder, Neurogenic Detrusor Overactivity Trial in Worldwide (Solifenacin succinate suspension 5 mg)

Completed
  • Overactive Bladder
  • Neurogenic Detrusor Overactivity
  • Solifenacin succinate suspension 5 mg
  • Gent, Belgium
  • +6 more
Oct 26, 2018

Is Nerve Growth FactorUseful Biomarker in Neurogenic Bladder

Completed
  • Spinal Cord Injury
  • +2 more
    • Nottwil, LU, Switzerland
      Swiss Paraplegic Centre
    Nov 16, 2015

    Spinal Cord Injury, Neurogenic Detrusor Overactivity Trial in Winnipeg, Toronto (Oxybutynin Cl, Trospium Cl, Darifenacin

    Completed
    • Spinal Cord Injury
    • Neurogenic Detrusor Overactivity
    • Oxybutynin Cl
    • +2 more
    • Winnipeg, Manitoba, Canada
    • +1 more
    Apr 4, 2013

    Overactive Bladder, Neurogenic Detrusor Overactivity Trial in United States (Fesoterodine)

    Completed
    • Overactive Bladder
    • Neurogenic Detrusor Overactivity
    • Little Rock, Arkansas
    • +8 more
    Nov 20, 2011

    Neurogenic Detrusor Overactivity Trial in Toronto (Botulinum toxin A)

    Completed
    • Neurogenic Detrusor Overactivity
    • Botulinum toxin A
    • Toronto, Ontario, Canada
      Sunnybrook Health Sciences Centre
    Mar 22, 2010